or Try an Advanced Search...

    Specialty Drugs Stocks List

    Symbol Grade Name % Change
    RZLT A Rezolute, Inc. 0.36
    BHC A Bausch Health Companies Inc. 6.30
    DCTH B Delcath Systems, Inc. -3.58
    FNCH B Finch Therapeutics Group, Inc. 1.37
    BCAX B Bicara Therapeutics Inc. 1.39
    CUE B Cue Biopharma, Inc. -5.59
    TAK C Takeda Pharmaceutical Company Limited 0.14
    PRTC D PureTech Health plc 2.36
    OTLK D Outlook Therapeutics, Inc. 5.03
    RAPT D RAPT Therapeutics, Inc. 5.19
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Health Care Plans Medical Care Medical Devices
    Related Stock Lists: Biotechnology Biopharmaceutical Life Sciences Medicine Pharmacy Cancer Immunology Monoclonal Antibody Antibodies Cancer Treatment Clinical Medicine Colitis Diarrhea Gastroenterology Gastrointestinal Medication Pharmaceutical Products Tumor Ulcerative Colitis Abdominal Pain

    Related ETFs - A few ETFs which own one or more of the above listed Specialty Drugs stocks.

    Symbol Grade Name Weight
    BIS C ProShares UltraShort Nasdaq Biotechnology 6.12
    IHF D iShares U.S. Health Care Providers ETF 4.85
    RTH A Market Vectors Retail ETF 4.84
    PBE C PowerShares Dynamic Biotech & Genome 4.77
    LBAY D Leatherback Long/Short Alternative Yield ETF 4.5
    View all Specialty Drugs ETFs...
    Compare ETFs
    Compare BIS to PBE Compare IHF to RTH Compare PBE to LBAY

        Specialty Drugs Stocks Recent News

        Date Stock Title
        Nov 1 BHC Bausch Health Q3 Earnings and Revenues Top, Xifaxan Boosts Sales
        Nov 1 TAK Takeda Pharmaceutical Company Limited 2025 Q2 - Results - Earnings Call Presentation
        Nov 1 TAK Takeda Pharmaceutical Company Limited (TAK) Q2 2025 Earnings Call Transcript
        Oct 31 TAK HUTCHMED to Receive First Commercial Milestone Payment Following Over US$200 Million in FRUZAQLA® (fruquintinib) Sales by Takeda
        Oct 31 BHC Bausch Health Companies Inc (BHC) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...
        Oct 31 TAK Takeda Pharmaceutical reports H1 results, revises FY forecast
        Oct 31 TAK Takeda Announces Strong First Half FY2024 Results and Raises Full Year Outlook
        Oct 31 BHC Bausch Health Companies Inc. 2024 Q3 - Results - Earnings Call Presentation
        Oct 31 BHC Bausch Health Companies, Inc. (BHC) Q3 2024 Earnings Call Transcript
        Oct 31 BHC Compared to Estimates, Bausch (BHC) Q3 Earnings: A Look at Key Metrics
        Oct 31 BHC Bausch Health (BHC) Beats Q3 Earnings and Revenue Estimates
        Oct 30 BHC Bausch: Q3 Earnings Snapshot
        Oct 30 BHC Bausch Health raises 2024 revenue guidance
        Oct 30 BHC Bausch Health Companies GAAP EPS of -$0.23 misses by $0.37, revenue of $2.51B beats by $90M
        Oct 30 BHC Bausch Health up 5.5% in New York Trade as It Reports a Higher Adjusted Third-Quarter Profit, Ups Guidance
        Oct 30 BHC Bausch Health Announces Third Quarter 2024 Results
        Oct 30 TAK Takeda Pharmaceutical FQ2 Earnings Preview
        Oct 30 BHC Bausch + Lomb (BLCO) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
        Oct 30 BHC Bausch + Lomb (BLCO) Q3 Earnings and Revenues Top Estimates
        Oct 30 BHC Bausch + Lomb: Q3 Earnings Snapshot
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Health Care Plans Medical Care Medical Devices
        Related Stock Lists: Biotechnology Biopharmaceutical Medicine Pharmacy Life Sciences Cancer Clinical Medicine Autoimmune Disorders Cancer Treatment Chemotherapy Disease Immune Disorders Immunology Monoclonal Antibody Oncology S&P 500 Abdominal Pain Alzheimer's Disease Antibodies Antineoplastic Drugs
        Specialty Drugs

        Specialty drugs are medications that are used to treat complex and chronic conditions, such as cancer, multiple sclerosis, and rheumatoid arthritis. They are typically more expensive than traditional medications and require special handling, storage, and administration. Specialty drugs may also require special monitoring and close follow-up with a healthcare provider.

        Browse All Tags